The FTIR has a detection limit of approximately 5%. Substances below this level may not appear in results — even if they are toxic or affect the potency of your sample.
When possible, we may provide a percentage estimate based on what the FTIR detects. These numbers are generated by software and reflect only the visible components — not the full composition of the sample. The FTIR cannot isolate individual substances in complex mixtures, so any percentage estimates are approximate. They may not reflect actual potency, and similar-looking samples can yield different results – therefore we do not provide purity testing. Any percentages we offer are estimates based on the visible ingredients identified through FTIR spectroscopy. Since this method does not account for the entire sample, undetected ingredients below the detection threshold may influence the composition. The percentages are intended only as a general indication of how the identified ingredients are distributed within the sample. Due to this, any percentages provided cannot be used to calculate milligram quantities within a sample. Our results should not be used to determine exact dosages.
Additionally, a sample may not reflect the full composition of a drug. For example, testing part of a pill may not represent the rest. Cross-contamination between samples stored together can also affect results.
When we detect only one substance, we don’t provide a percentage because other ingredients might still be present below the 5% detection limit.
Treat any percentage result as a rough guideline, not a precise measurement.
Tests highlighted in red indicate particularly dangerous or unexpected results. Flagged samples can alslo be viewed on our Alerts page.
We also use test strips to detect the presence of fentanyl, benzodiazapenes, and lysergamide (LSD).
The results provided are strictly for personal use and educational purposes. They must not be published, distributed, or shared publicly in any form. Unauthorized sharing, reproduction, or publication of these results is strictly prohibited and may result in disciplinary action.
If you find our results shared elsewhere, please be aware that such use is unauthorized and we do not condone it. Images or representations of our results can be easily replicated or altered online, potentially containing misleading or false information. We strongly recommend testing your own samples to ensure accuracy and reliability.
Category: Opioid Light Yellow Powder Code: winter tan
Down
Caffeine
50-55%
Fentanyl
25-30%
Erythritol
10-15%
Uncertain Match
5-10%
Fentanyl: Positive Benzodiazepine: Positive
The uncertain match in this sample shares similarities with a number of benzodiazepines, but can not be confirmed as such. The benzodiazepine content in this sample may be as much as 5-10%.
Vancouver, BC
10/14/2023
Category: Opioid Pink Powder Code: winter pink
Down
Caffeine
50-55%
Fentanyl
25-30%
Erythritol
15-20%
Fentanyl: Positive Benzodiazepine: Positive
Vancouver, BC
10/14/2023
Category: Opioid Dark Pink Chunk
Down
Xylazine
30-35%
Bromazolam
25-30%
Caffeine
20-25%
Uncertain Match
10-15%
Fentanyl: Positive Benzodiazepine: Positive
This sample is being sold as down. This sample presents an extreme risk of a complex overdose due to the presence of xylazine and a high concentration of a benzodiazepine, as well as being fentanyl positive.
Vancouver, BC
10/14/2023
Category: Opioid Dark Pink Chunk
Down
Xylazine
90-95%
Uncertain Match
5-10%
Fentanyl: Positive Benzodiazepine: Positive
This sample is being sold as down. it is extremely risky due to the fact that it is almost entirely xylazine that is also positive for both fentanyl and benzodiazepines. The risk for a complex overdose is very high.
Vancouver, BC
10/14/2023
Category: Psychedelic White Powder Code: pipsqueak 7
2C-B HCl
2C-B HCl
65-70%
2C-Family
30-35%
Fentanyl: Negative
Another member of the 2C family of substances is present in this sample. Unable to verify which specific 2C substance comprises the second component.